SAFETY INFORMATION
| Signal word | Warning |
|---|---|
| Pictogram(s) |
 Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral |
| Precautionary Statement Codes |
P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
COMPUTED DESCRIPTORS
| Molecular Weight | 619.1 g/mol |
|---|---|
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 14 |
| Exact Mass | 618.1867896 g/mol |
| Monoisotopic Mass | 618.1867896 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 967 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
Description
Acetoxy Empagliflozin can be used as Empagliflozin intermediates and pharmaceutical intermediates.
RELATED SUPPLIERS
Ralington Pharma
1Y
product:[(2R,3R,4R,5S,6S)-3,4,5-tris(acetyloxy)-6-[4-chloro-3-((4-[(3S)-oxolan-3-yloxy]phenyl)methyl)phenyl]oxan-2-yl]methyl acetate 915095-99-7 98%
Vijaya Pharma And Life Science
1Y
product:[(2R,3R,4R,5S,6S)-3,4,5-tris(acetyloxy)-6-[4-chloro-3-((4-[(3S)-oxolan-3-yloxy]phenyl)methyl)phenyl]oxan-2-yl]methyl acetate 98%